EP1219639A4 - Stoffe zur extrakorporalen zirkulatin, adsorptionsmittel für diabetische komplikationsfaktoren, behälter zur entfernung diabetscher komplikationsfaktoren, und verfahren zur entfernung von diabetischen komplikationsfaktoren - Google Patents

Stoffe zur extrakorporalen zirkulatin, adsorptionsmittel für diabetische komplikationsfaktoren, behälter zur entfernung diabetscher komplikationsfaktoren, und verfahren zur entfernung von diabetischen komplikationsfaktoren

Info

Publication number
EP1219639A4
EP1219639A4 EP00957072A EP00957072A EP1219639A4 EP 1219639 A4 EP1219639 A4 EP 1219639A4 EP 00957072 A EP00957072 A EP 00957072A EP 00957072 A EP00957072 A EP 00957072A EP 1219639 A4 EP1219639 A4 EP 1219639A4
Authority
EP
European Patent Office
Prior art keywords
diabetic complication
complication factors
eliminating
factors
adsorbents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00957072A
Other languages
English (en)
French (fr)
Other versions
EP1219639A1 (de
Inventor
Shinji Shimizu
Masahiro Kubota
Hideo Akiyama
Mina Usui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of EP1219639A1 publication Critical patent/EP1219639A1/de
Publication of EP1219639A4 publication Critical patent/EP1219639A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • External Artificial Organs (AREA)
EP00957072A 1999-09-08 2000-09-08 Stoffe zur extrakorporalen zirkulatin, adsorptionsmittel für diabetische komplikationsfaktoren, behälter zur entfernung diabetscher komplikationsfaktoren, und verfahren zur entfernung von diabetischen komplikationsfaktoren Withdrawn EP1219639A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25446399 1999-09-08
JP25446399 1999-09-08
PCT/JP2000/006172 WO2001018060A1 (fr) 1999-09-08 2000-09-08 Materiaux de circulation extracorporelle, adsorbants de facteurs de complication diabetique, reservoirs servant a eliminer des facteurs de complication diabetique et procede d'elimination de facteurs de complication diabetique

Publications (2)

Publication Number Publication Date
EP1219639A1 EP1219639A1 (de) 2002-07-03
EP1219639A4 true EP1219639A4 (de) 2009-03-25

Family

ID=17265386

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00957072A Withdrawn EP1219639A4 (de) 1999-09-08 2000-09-08 Stoffe zur extrakorporalen zirkulatin, adsorptionsmittel für diabetische komplikationsfaktoren, behälter zur entfernung diabetscher komplikationsfaktoren, und verfahren zur entfernung von diabetischen komplikationsfaktoren

Country Status (2)

Country Link
EP (1) EP1219639A4 (de)
WO (1) WO2001018060A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1192963A4 (de) * 2000-04-05 2004-08-25 Toray Industries Adsorbentien für proteine der gruppe high mobility protein und säule zum reinigen von körperflüssigkeiten
GEP20105110B (en) 2004-08-03 2010-11-10 Transtech Pharma Inc Rage fusion proteins and their use
KR101397386B1 (ko) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법
SG171670A1 (en) 2006-05-05 2011-06-29 Transtech Pharma Inc Rage fusion proteins, formulations, and methods of use thereof
KR101595634B1 (ko) 2007-06-14 2016-02-18 갈락티카 파마슈티칼스, 인크. Ｒａｇｅ 융합 단백질
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
RU2553225C2 (ru) 2008-05-23 2015-06-10 Сива Корпорейшн Способ облегчения регенерации
AU2010240569A1 (en) 2009-04-20 2011-10-20 Pfizer Inc. Control of protein glycosylation and compositions and methods relating thereto
EP2488228A4 (de) * 2009-10-18 2018-03-21 Glycorex AB Verfahren und produkte zur blutbehandlung und -reinigung
ES2861359T3 (es) 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
ES2725852T3 (es) * 2010-09-27 2019-09-27 Siwa Corp Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
JP5773415B2 (ja) * 2011-04-19 2015-09-02 学校法人 東洋大学 糖化タンパク質の検出方法および糖化タンパク質の検出のためのバイオセンサーチップ
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
BR112015032134B1 (pt) 2013-06-24 2022-05-10 Exthera Medical Corporation Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
US9058626B1 (en) 2013-11-13 2015-06-16 Jpmorgan Chase Bank, N.A. System and method for financial services device usage
EP3194439B1 (de) 2014-09-19 2022-01-19 Siwa Corporation Anti-age-antikörper zur behandlung von entzündungs- und autoimmunerkrankungen
US10857283B2 (en) 2014-09-22 2020-12-08 Exthera Medical Corporation Wearable hemoperfusion device
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
HUE058854T2 (hu) 2016-02-19 2022-09-28 Siwa Corp Módszer és készítmény a rák kezelésére, az áttétes rákos sejtek elpusztítására és a rák áttétképzõdésének megelõzésére a fejlett glikációs végtermékek (AGE) elleni antitest alkalmazásával
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
KR20180133452A (ko) 2016-04-15 2018-12-14 시와 코퍼레이션 신경퇴행성 질환을 치료하기 위한 항-노화 항체
JP2019518763A (ja) 2016-06-23 2019-07-04 シワ コーポレーション 様々な疾患及び障害の治療において使用するためのワクチン
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
CA3059803A1 (en) 2017-04-13 2018-10-18 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039125A1 (en) * 1996-04-16 1997-10-23 Schering Aktiengesellschaft Patente Antibodies against the advanced glycosylation end-product receptor and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10332693A (ja) * 1997-05-29 1998-12-18 Tokuyama Corp 被検体の前処理方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039125A1 (en) * 1996-04-16 1997-10-23 Schering Aktiengesellschaft Patente Antibodies against the advanced glycosylation end-product receptor and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAYNES JOHN W ET AL: "Role of oxidative stress in diabetic complications: A new perspective on an old paradigm", DIABETES, vol. 48, no. 1, January 1999 (1999-01-01), pages 1 - 9, XP001023927, ISSN: 0012-1797 *
WAUTIER J-L ET AL: "ADVANCED GLYCATION END PRODUCTS (AGES) ON THE SURFACE OF DIABETIC ERYTHROCYTES BIND TO THE VESSEL WALL VIA A SPECIFIC RECEPTOR INDUCING OXIDANT STRESS IN THE VASCULATURE: A LINK BETWEEN SURFACE-ASSOCIATED AGES AND DIABETIC COMPLICATIONS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, vol. 91, 1 August 1994 (1994-08-01), pages 7742 - 7746, XP002036216, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2001018060A1 (fr) 2001-03-15
EP1219639A1 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
EP1219639A4 (de) Stoffe zur extrakorporalen zirkulatin, adsorptionsmittel für diabetische komplikationsfaktoren, behälter zur entfernung diabetscher komplikationsfaktoren, und verfahren zur entfernung von diabetischen komplikationsfaktoren
EP0704199A4 (de) Transfusionsbehälter,transfusionspräparat sowie umfassendes,vitamine enthaltendes,kaloriereiches präparat
AU3001299A (en) Method for manufacturing, filling and packaging medical containers
AU3083301A (en) Improved tissue engineered blood vessels and methods and apparatus for their manufacture
HUP0200556A3 (en) Medicament for treating diabetes
EP1181063B8 (de) Plastikbehälter mit inneren Taschen und Methoden zum Herstellen solcher Behälter
AU2001277719A1 (en) Stent for blood vessel and material for stent for blood vessel
AU7466500A (en) Method and apparatus for detecting blood characteristics including hemoglobin
PL340908A1 (en) Laminated material, packaging unit made thereof and packaging method
MXPA02000566A (es) Metodo para envolver recipientes de comestibles y comestibles.
AU5844300A (en) Eugenia jambolina fruit extracts for treating diabetes
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
AU7773001A (en) Acylacetonitriles, process for preparation thereof and miticides containing the same
AU2001252807A1 (en) Method and apparatus for collecting and transporting liquids, specifically blood
ZA200204374B (en) Pre-filled syringe and method for making same.
AU5761299A (en) Highly pure polystyrene, method for preparing the same and disposable food container using the same
AU1967897A (en) Method for treatment of insulin resistance
AU4294800A (en) Method and apparatus for packaging disposable articles as well as the articles obtained
ZA9810836B (en) Sterilizing method for medical sterilization packaging and injection pack.
AU1800000A (en) Medicine container and syringe
GB9801395D0 (en) Method and apparatus for packaging infusion packaging
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
AU6898700A (en) Method for identifying compounds for treatment of insulin resistance
EP1466624A4 (de) Arzneistoff zur geweberegenerierung sowie gefäss und verfahren dafür
GB2342203B (en) Drug packaging method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020402

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20090220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090422